Cargando…

P1363: NOVEL DUAL-TARGETING AND SURFACE-ENGINEERED BIO-ORTHOGONALLY LENTIVIRAL VECTORS FOR IN VIVO CAR-T CELLS GENERATION

Detalles Bibliográficos
Autores principales:	Chen, Zhaozhao, Hu, Yu, Mei, Heng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430682/ http://dx.doi.org/10.1097/01.HS9.0000972340.57544.97

Ejemplares similares

Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells
por: Huckaby, Justin T, et al.
Publicado: (2021)

Physiological lentiviral vectors for the generation of improved CAR-T cells
por: Tristán-Manzano, María, et al.
Publicado: (2022)

Physiological lentiviral vectors for the generation of improved CAR-T cells
por: Tristán-Manzano, María, et al.
Publicado: (2022)

Postexit Surface Engineering of Retroviral/Lentiviral Vectors
por: Metzner, Christoph, et al.
Publicado: (2013)

Dasatinib is a potent enhancer for CAR T cell generation by CD3-targeted lentiviral vectors
por: Braun, Angela H., et al.
Publicado: (2022)

Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineering
por: Michels, Kathryn R, et al.
Publicado: (2023)

Surface-Engineered Lentiviral Vectors for Selective Gene Transfer into Subtypes of Lymphocytes
por: Frank, Annika M., et al.
Publicado: (2018)

Monitoring CAR T cell generation with a CD8-targeted lentiviral vector by single-cell transcriptomics
por: Charitidis, Filippos T., et al.
Publicado: (2021)

Monitoring CAR T cell generation with a CD8-targeted lentiviral vector by single-cell transcriptomics
por: Charitidis, Filippos T., et al.
Publicado: (2022)

The Application of Bio-orthogonality for In Vivo Animal Imaging
por: Yang, Jun, et al.
Publicado: (2023)

Laboratory-Scale Lentiviral Vector Production and Purification for Enhanced Ex Vivo and In Vivo Genetic Engineering
por: Soldi, Monica, et al.
Publicado: (2020)

Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cells
por: Cordes, Nicole, et al.
Publicado: (2021)

Bio-Orthogonal Mediated Nucleic Acid Transfection of Cells via Cell Surface Engineering
por: O’Brien, Paul J., et al.
Publicado: (2017)

Production of human CAR-NK cells with lentiviral vectors and functional assessment in vitro
por: Portillo, Ana L., et al.
Publicado: (2021)

Metasurface of Combined Semicircular Rings with Orthogonal Slit Pairs for Generation of Dual Vector Beams
por: Kong, Qian, et al.
Publicado: (2021)

Establishing functional lentiviral vector production in a stirred bioreactor for CAR-T cell therapy
por: Tang, Qu-Lai, et al.
Publicado: (2021)

Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies
por: Picanço-Castro, Virgínia, et al.
Publicado: (2020)

Scaffold Free Bio-orthogonal Assembly of 3-Dimensional Cardiac Tissue via Cell Surface Engineering
por: Rogozhnikov, Dmitry, et al.
Publicado: (2016)

Comparison of the efficacy of second and third generation lentiviral vector transduced CAR CD19 T cells for use in the treatment of acute lymphoblastic leukemia both in vitro and in vivo models
por: Sawaisorn, Piamsiri, et al.
Publicado: (2023)

Engineering lentiviral vectors for modulation of dendritic cell apoptotic pathways
por: Wang, James CM, et al.
Publicado: (2013)

Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells
por: Tristán-Manzano, María, et al.
Publicado: (2023)

Production of lentiviral vectors
por: Merten, Otto-Wilhelm, et al.
Publicado: (2016)

Lentiviral Vector Bioprocessing
por: Perry, Christopher, et al.
Publicado: (2021)

Generation of a bovine cell line for gene engineering using an HIV-1-based lentiviral vector
por: Morizako, Nanami, et al.
Publicado: (2022)

Engineering protein theranostics using bio-orthogonal asparaginyl peptide ligases
por: Wang, Zhen, et al.
Publicado: (2021)

In vitro and in vivo gene delivery using a lentiviral vector
por: Gouze-Decaris, E, et al.
Publicado: (2001)

Further Elucidation of Galactose Utilization in Lactococcus lactis MG1363
por: Solopova, Ana, et al.
Publicado: (2018)

Engineering fusogenic molecules to achieve targeted transduction of enveloped lentiviral vectors
por: Lei, Yuning, et al.
Publicado: (2009)

Lentiviral Vectors for T Cell Engineering: Clinical Applications, Bioprocessing and Future Perspectives
por: Labbé, Roman P., et al.
Publicado: (2021)

Engineering Novel Lentiviral Vectors for Labelling Tumour Cells and Oncogenic Proteins
por: Akgül, Seçkin, et al.
Publicado: (2022)

Using bio-orthogonally catalyzed lethality strategy to generate mitochondria-targeting anti-tumor metallodrugs in vitro and in vivo
por: Xue, Xuling, et al.
Publicado: (2020)

Generation of non-human primate CAR Tregs using artificial antigen-presenting cells, simian tropic lentiviral vectors, and antigen-specific restimulation
por: Ellis, Gavin I., et al.
Publicado: (2022)

Orthogonal dual-modification of proteins for the engineering of multivalent protein scaffolds
por: Mühlberg, Michaela, et al.
Publicado: (2015)

The Inside Out of Lentiviral Vectors
por: Durand, Stéphanie, et al.
Publicado: (2011)

Clinical use of lentiviral vectors
por: Milone, Michael C., et al.
Publicado: (2018)

Special Issue “Lentiviral Vectors”
por: Takeuchi, Yasuhiro
Publicado: (2022)

Highly Efficient and Selective CAR-Gene Transfer Using CD4- and CD8-Targeted Lentiviral Vectors
por: Jamali, Arezoo, et al.
Publicado: (2019)

Bio-Orthogonal Nanogels for Multiresponsive Release
por: Alkanawati, Mohammad Shafee, et al.
Publicado: (2021)

Introduction to ‘Development of bio-orthogonal tools’
por: Zhang, Yan, et al.
Publicado: (2022)

Engineering orthogonal dual transcription factors for multi-input synthetic promoters
por: Brödel, Andreas K., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5q6r8ccbgd7eatj1tkh7kv5oi9